DrugPatentWatch Database Preview

Jubilant Generics Company Profile

« Back to Dashboard

What is the competitive landscape for JUBILANT GENERICS, and what generic and branded alternatives to JUBILANT GENERICS drugs are available?

JUBILANT GENERICS has thirty-nine approved drugs.

Summary for Jubilant Generics

US Patents:	0
Tradenames:	35
Ingredients:	34
NDAs:	39
Patent Litigation for Jubilant Generics:	See patent lawsuits for Jubilant Generics

Drugs and US Patents for Jubilant Generics

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Jubilant Generics	FELODIPINE	felodipine	TABLET, EXTENDED RELEASE;ORAL	203983-001	Aug 19, 2016	AB	RX	No	No
Jubilant Generics	OLMESARTAN MEDOXOMIL	olmesartan medoxomil	TABLET;ORAL	205482-001	Apr 24, 2017	AB	RX	No	No
Jubilant Generics	RISPERIDONE	risperidone	TABLET, ORALLY DISINTEGRATING;ORAL	090839-004	Nov 4, 2011	AB	RX	No	No
Jubilant Generics	LEVOFLOXACIN	levofloxacin	TABLET;ORAL	203613-001	Jun 19, 2015	AB	RX	No	No

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Jubilant Cadista
• Jubilant Draximage
• Jubilant Generics
• Jubilant Hollistrstr